Memorial Sloan Kettering Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2020

  1. Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

    Cancer Medicine, Vol. 9, Núm. 22, pp. 8468-8479

2018

  1. Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia

    New England Journal of Medicine, Vol. 378, Núm. 12, pp. 1107-1120

2010

  1. Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

    Blood, Vol. 116, Núm. 25, pp. 5650-5659